UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 144

Sortiert nach

E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy

Frontiers in immunology, 2018-01, Vol.8, p.1878-1878

2018

Volltextzugriff (PDF)

Congenital disorders of glycosylation (CDG): state of the art in 2022

Orphanet journal of rare diseases, 2023-10, Vol.18 (1), p.1-329, Article 329

2023

Volltextzugriff (PDF)

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease

Frontiers in neuroscience, 2018-06, Vol.12, p.381-381

2018

Volltextzugriff (PDF)

Sialyl-tn in cancer: (how) did we miss the target?

Biomolecules, 2012-10, Vol.2 (4), p.435-466

2012

Volltextzugriff (PDF)

Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

Orphanet journal of rare diseases, 2022-07, Vol.17 (1), p.1-303, Article 303

2022

Volltextzugriff (PDF)

Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8725

2022

Volltextzugriff (PDF)

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

Scientific reports, 2018-08, Vol.8 (1), p.12196-16, Article 12196

2018

Volltextzugriff (PDF)

Sialyl Lewis[sup.X/A] and Cytokeratin Crosstalk in Triple Negative Breast Cancer

Cancers, 2023-02, Vol.15 (3)

2023

Volltextzugriff (PDF)

Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer

Cancers, 2023-01, Vol.15 (3), p.731

2023

Volltextzugriff (PDF)

New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach

Journal of clinical medicine, 2020-07, Vol.9 (7), p.2092

2020

Volltextzugriff (PDF)

MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells

Pharmaceutics, 2020-03, Vol.12 (3), p.249

2020

Volltextzugriff (PDF)

Artificial Intelligence in Epigenetic Studies: Shedding Light on Rare Diseases

Frontiers in molecular biosciences, 2021-05, Vol.8, p.648012-648012

2021

Volltextzugriff (PDF)

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer

Cancers, 2021-08, Vol.13 (16), p.4074

2021

Volltextzugriff (PDF)

CDG and immune response: From bedside to bench and back

Journal of inherited metabolic disease, 2020-01, Vol.43 (1), p.90-124

2020

Volltextzugriff (PDF)

Blood Supply to the Integument of the Abdomen of the Rat: A Surgical Perspective

Plastic and reconstructive surgery. Global open, 2017-09, Vol.5 (9), p.e1454-e1454

2017

Volltextzugriff (PDF)

Dendritic cells: a spot on sialic Acid

Frontiers in immunology, 2013-12, Vol.4, p.491-491

2013

Volltextzugriff (PDF)

Optimization of an Arterialized Venous Fasciocutaneous Flap in the Abdomen of the Rat

Plastic and reconstructive surgery. Global open, 2017-08, Vol.5 (8), p.e1436-e1436

2017

Volltextzugriff (PDF)

A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation

International journal of environmental research and public health, 2022-06, Vol.19 (11), p.6829

2022

Volltextzugriff (PDF)

Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage

Oncotarget, 2017-08, Vol.8 (33), p.54506-54517

2017

Volltextzugriff (PDF)

Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods

Biological procedures online, 2018-02, Vol.20 (1), p.4-4, Article 4

2018

Volltextzugriff (PDF)

Inhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and ERK 1/2 and p38 MAPK activation

Molecular oncology, 2018-05, Vol.12 (5), p.579-593

2018

Volltextzugriff (PDF)

The phagocytic capacity and immunological potency of human dendritic cells is improved by [alpha]2,6-sialic acid deficiency

Immunology, 2013-03, Vol.138 (3), p.235

2013

Volltextzugriff (PDF)

Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis

Glycoconjugate journal, 2008-04, Vol.25 (3), p.259-268

2008

Volltextzugriff (PDF)

Systemic humoral responses of non-muscle-invasive bladder cancer during BCG treatment: less is more

Journal of cancer metastasis and treatment, 2017-07, Vol.3 (7), p.116

2017

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(138)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

E-Selectin Ligands in the Human Mononuclear Phagocyte System: Implications for Infection, Inflammation, and Immunotherapy

Congenital disorders of glycosylation (CDG): state of the art in 2022

Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson's Disease

Sialyl-tn in cancer: (how) did we miss the target?

Stakeholders’ views on drug development: the congenital disorders of glycosylation community perspective

Systematic Review: Drug Repositioning for Congenital Disorders of Glycosylation (CDG)

Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2-6 sialic acids

Sialyl Lewis[sup.X/A] and Cytokeratin Crosstalk in Triple Negative Breast Cancer

Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer

New Insights into Immunological Involvement in Congenital Disorders of Glycosylation (CDG) from a People-Centric Approach

MHC Class I Stability is Modulated by Cell Surface Sialylation in Human Dendritic Cells

Artificial Intelligence in Epigenetic Studies: Shedding Light on Rare Diseases

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy against Estrogen Receptor-Positive Breast Cancer

CDG and immune response: From bedside to bench and back

Blood Supply to the Integument of the Abdomen of the Rat: A Surgical Perspective

Dendritic cells: a spot on sialic Acid

Optimization of an Arterialized Venous Fasciocutaneous Flap in the Abdomen of the Rat

Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications

A Community-Led Approach as a Guide to Overcome Challenges for Therapy Research in Congenital Disorders of Glycosylation

Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage

Antitumor Efficacy of Human Monocyte-Derived Dendritic Cells: Comparing Effects of two Monocyte Isolation Methods

Inhibition of fucosylation in human invasive ductal carcinoma reduces E‐selectin ligand expression, cell proliferation, and ERK 1/2 and p38 MAPK activation

The phagocytic capacity and immunological potency of human dendritic cells is improved by [alpha]2,6-sialic acid deficiency

Surface α2-3- and α2-6-sialylation of human monocytes and derived dendritic cells and its influence on endocytosis

Systemic humoral responses of non-muscle-invasive bladder cancer during BCG treatment: less is more

Aktive Filter

Suchergebnisse filtern